10-Jun-2009 - The FDA has revised its guidance on ICH Q8, adding an annex that clarifies the original document and adds the principles of quality by design (QbD).
08-Jun-2009 - At TIDES 2009 RXi Pharmaceuticals presented preclinical data on its RNA technologies, including research into sdRNA that is delivered without a vehicle and undergoes spontaneous cellular uptake.
04-Jun-2009 - 3M Drug Delivery Technologies has expanded its respiratory drug delivery system offering with its Taper DPI which, it claims, makes carrier compounds unnecessary and will help drug formulators save millions.
03-Jun-2009 - UK researchers have boosted the bioavailability of the tomato skin extract lycopene and produced a pill that they claim can reduce “bad” LDL cholesterol by more than 90 per cent.
02-Jun-2009 - The latest work on siRNA delivery is focused on in a special edition of Molecular Pharmaceutics, which details the techniques researchers are using to target cells and make more effective therapeutics.
01-Jun-2009 - US scientists at Harvard University’s Rowland Institute have described a way of making large numbers of controllable nano-propellers that, despite being at an early stage of development, may one day be used to deliver drugs.
18-May-2009 - Archimedes Pharma has presented positive Phase III results of its treatment for breakthrough cancer pain, NasalFent, which uses the company’s PecSys delivery technology.
11-May-2009 - A new ready-to-use WFI prefilled syringe for the reconstitution of lyophilised drugs is likely to win fans among producers of high-value biopharma drugs according to West Pharmaceutical Services’s VP of European marketing, Mike Schaefers.
07-May-2009 - SurModics has completed the three year Phase I trial of I-vation TA (triamcinolone acetonide), which uses a novel drug delivery system capable of sustained ocular release of a therapeutic.
05-May-2009 - Axentis Pharma has received orphan drug designation (ODD) in the US for its cystic fibrosis treatment, which uses liposomes to deliver prolonged high-concentrations of a therapeutic to the infected area.
30-Apr-2009 - Eli Lilly and Amylin Pharmaceuticals are jointly developing an exenatide once weekly pen device, which should provide a more convenient way for diabetics to treat themselves.
29-Apr-2009 - Erectile dysfunction could be treated by a nanoparticle formulation applied directly to the penis, according to research, reducing the side effects that can occur when taking drugs like Viagra.
22-Apr-2009 - Sinobiopharma is seeking a Chinese patent covering the manufacture of capsule forms of the heart drug perindopril, claiming it is the first company in the world to produce the medication in this easy to swallow format.
16-Apr-2009 - The drive to license needle-free delivery methods continues with Zealand Pharma signing a deal to use its peptide optimisation technology with Vyteris’ controlled transdermal patch.
07-Apr-2009 - MRSA could be treated through a combination of an antimicrobial drug, a peptide and light, according to researchers who have hailed the treatment as a “magic bullet”.
02-Apr-2009 - The search for more convenient diabetes treatments continues, with Altea Therapeutics reaching a $46m agreement with Eli Lilly and Amylin to develop a transdermal patch administering Byetta.
31-Mar-2009 - Flugen has secured the exclusive rights to Ratio’s novel vaccine delivery technology, which is a disposable micro-device that it claims can improve efficacy and compliance.
25-Mar-2009 - US drug delivery specialist Hospira will reduce its workforce by around 10 per cent, or 1,400 employees, over the next 24 months as part of its $140m (€104m) a year “Project Fuel” cost cutting and efficiency drive.
24-Mar-2009 - US RNA interference (RNAi) specialist MDRNA has signed a non-exclusive licensing deal granting Swiss drug giant Novartis access to its liposomal siRNA delivery technology platform.
09-Mar-2009 - UK drugmaker SkyePharma may reduce the workforce at its production plant in Lyon, France by a third after “long-running” underutilisation of its manufacturing capacity.
25-Feb-2009 - The therapeutic index of Tekmira’s SNALP technology, which has been designed to deliver siRNA, has been improved by 5-10 times, according to new data.
19-Feb-2009 - PII has expanded the range of drug delivery solutions it can offer clients through collaboration with NexMed, which gives the contract formulation company access to transdermal technology.
18-Feb-2009 - MannKind, one of the inhaled-insulin market’s only remaining players, has posted higher than expected Q4 losses as costs for development of its lead product candidate Afresa increase ahead of its submission to the US FDA.
09-Feb-2009 - Researchers have raised concerns that wirelessly activated drug delivery devices could be hacked to steal personal information or release potentially fatal doses of a therapeutic.
03-Feb-2009 - The EU has backed a €15.9m ($20.4m) research collaboration that will seek to develop drug delivery vehicles that can be tracked through the body with MRI and triggered using ultrasound.